• Please log in or register to access this feature.

Original Article

You have free access to this content

Impaired macrophage phagocytosis in non-eosinophilic asthma

  1. J. L. Simpson1,2,
  2. P. G. Gibson1,2,
  3. I. A. Yang3,4,
  4. J. Upham3,5,
  5. A. James6,
  6. P. N. Reynolds7,8,
  7. S. Hodge7,8,*,
  8. AMAZES Study Research Group

Article first published online: 24 DEC 2012

DOI: 10.1111/j.1365-2222.2012.04075.x

Issue

Clinical & Experimental Allergy

Clinical & Experimental Allergy

Volume 43, Issue 1, pages 29–35, January 2013

Additional Information

How to Cite

Cite this as: J. L. Simpson , P. G. Gibson , I. A. Yang , J. Upham , A. James , P. N. Reynolds , S. Hodge AMAZES Study Research Group, Clinical & Experimental Allergy 2013 (43) 29–35.

Author Information

  1. 1

    Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, Australia

  2. 2

    Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, Australia

  3. 3

    School of Medicine, The University of Queensland, St Lucia, Australia

  4. 4

    The Prince Charles Hospital, Chermside, Australia

  5. 5

    Princess Alexandra Hospital, Brisbane, Australia

  6. 6

    Sir Charles Gairdner Hospital, Perth, Australia

  7. 7

    Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia

  8. 8

    Lung Research Laboratory, Hanson Institute, Adelaide, Australia

* Correspondence:
S. Hodge, Lung Research, Hanson Institute, Frome Rd, Adelaide 5001, South Australia.
E-mail: sandra.hodge@health.sa.gov.au

Publication History

  1. Issue published online: 24 DEC 2012
  2. Article first published online: 24 DEC 2012
  3. Accepted manuscript online: 28 NOV 2012 12:48PM EST
  4. Manuscript Accepted: 11 JUL 2012
  5. Manuscript Revised: 25 JUN 2012
  6. Manuscript Received: 14 MAR 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (144K)

References

  • 1
    Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma. Chest 2001; 119:1329–36.
  • 2
    Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54–61.
    Direct Link:
  • 3
    Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875–9.
  • 4
    Berry M, Morgan A, Shaw DE et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62:1043–9.
  • 5
    McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV. Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. A large subgroup of mild-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185:612–9.
  • 6
    Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353:2213–4.
  • 7
    Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Am J Respir Crit Care Med 2000; 161:1185–90.
  • 8
    Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG. Interleukin-8 and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000; 161:769–74.
  • 9
    Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001–8.
  • 10
    Jatakanon A, Uasuf C, Maziak W, Lim SM, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160:1532–9.
  • 11
    Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57:643–8.
  • 12
    James AL, Elliot JG, Abramson MJ, Walters EH. Time to death, airway wall inflammation and remodelling in fatal asthma. Eur Respir J 2005; 26:429–34.
  • 13
    Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19:68–75.
  • 14
    Hodge S, Hodge G, Flower R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with COPD are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 81:289–96.
    Direct Link:
  • 15
    Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in COPD. Am J Respir Cell Mol Biol 2007; 37:748–55.
  • 16
    Hodge S, Hodge G, Jersmann H et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in COPD. Am J Respir Crit Care Med 2008; 178:139–48.
  • 17
    Hodge S, Hodge GL, Brozyna ST, Jersmann HPA, Holmes MD, Reynolds PN. Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro. Eur Respir J 2006; 28:486–95.
  • 18
    Hodge S, Hodge G, Holmes M, Reynolds PN. Increased apoptosis in the airways in COPD persists after smoking cessation. Eur Respir J 2005; 25:447–54.
  • 19
    Hodge S, Reynolds PN. Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects. Respirology 2012; 17:802–7.
    Direct Link:
  • 20
    Hodge S, Matthews G, Dean MM et al. Is there a therapeutic role for mannose binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. Am J Respir Cell Mol Biol 2009; 42:235–42.
  • 21
    Hodge S, Matthews G, Mukaro V et al. Cigarette smoke-induced changes to alveolar macrophage phenotype and function is improved by treatment with procysteine. Am J Respir Cell Mol Biol 2011; 44:673–81.
  • 22
    Huynh ML, Malcolm KC, Kotaru C et al. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 2005; 172:972–9.
  • 23
    Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2011. Available at: www.goldcopd.org/ (accessed 28 January 2012).
  • 24
    Gibson PG, Wlodarczyk JW, Hensley MJ et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998; 158:36–41.
  • 25
    Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1:176–83.
  • 26
    Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62:211–8.
  • 27
    Simpson JL, Scott RJ, Boyle MJ, Gibson PG. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 2005; 172:559–65.
  • 28
    Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol 2001; 280:L369–75.
  • 29
    Fitzpatrick AM, Holguin F, Teague WG, Brown LA. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 2008; 121:1372–8.
  • 30
    Oliver BG, Lim S, Wark P et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 2008; 63:519–25.
  • 31
    Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120:1917–22.
  • 32
    Kulkarni NS, Hollins F, Sutcliffe A et al. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in asthma. J Allergy Clin Immunol 2010; 126:61–9.
View Full Article (HTML) Get PDF (144K)